Department of Justice Awarded a Contract to MCKESSON CORPORATION for $22,281.35

Summary of Award

The JSON response object provides a comprehensive overview of a federal contract awarded to McKesson Corporation by the Department of Justice's Federal Prison System. This contract, categorized as a "DELIVERY ORDER," underscores the government's procurement of pharmaceuticals and related services. Here's a detailed breakdown of the contract and its relevant transactions.

### Overview of the Award

The award, identified by the ID **179014580**, is a part of a larger framework governed by the Department of Veterans Affairs. This specific contract was signed on January 24, 2025, and carries a total obligation of **$22,281.35**, implying it’s a firm commitment for the government to purchase products or services up to that amount. The nature of the contract, although limited in dollar value, plays a critical role in supporting federal facilities with necessary pharmaceuticals. ### Recipient Details: McKesson Corporation McKesson Corporation, headquartered in Irving, Texas, is a key player in pharmaceutical preparation manufacturing—a vital industry in distributing medical products and services. Known for its robust supply chain capabilities, McKesson provides pharmaceuticals, medical supplies, and healthcare information technology solutions. This positions it uniquely to meet the intricate needs of healthcare facilities, including those within the federal government. McKesson is characterized by several business categories, primarily as a "Corporate Entity Not Tax Exempt" and "U.S.-Owned Business," reflecting its significant standing in the corporate sector. Its role in delivering pharmaceutical preparations is aligned with the North American Industry Classification System (NAICS) code **325412**, emphasizing its specialization in producing ready-made pharmaceuticals. ### Transactional Details The contract features multiple transactions, each contributing incrementally to the total obligation. Here's a closer look at these transactions: 1. **January 24, 2025**: Initial funding of **$6,013.97** was recorded, marking the start of the disbursements under this contract. This transaction is noteworthy as it establishes the early allocation of funds pivotal for timely pharmaceutical delivery. 2. **February 26, 2025**: A subsequent transaction of **$3,245.28** further facilitated the ongoing supply chain in the delivery of necessary pharmaceuticals. This continuance indicates a proactive approach to ensuring continuous service delivery. 3. **March 10, 2025**: Continuing the contract’s momentum, $2,022.10 was transacted, maintaining the regular flow of supplies. 4. **March 17, 2025**: Another installment of **$5,000** signifies sustained engagement and fulfillment of order requirements relevant for the Department of Justice’s Federal Prison System. 5. **April 10, 2025**: The latest transaction of **$6,000** highlights the ongoing commitment towards fulfilling the total obligation, ensuring continuous pharmaceutical support. All these transactions are executed under the DEF Code "Q," symbolizing designated funding for specific areas, probably related to medical supplies in this context. ### Contract and Competition The contract was awarded based on "FULL AND OPEN COMPETITION," suggesting McKesson Corporation succeeded in a competitive bidding process demonstrating value and capability. It's important to underscore that the department used "NEGOTIATED PROPOSAL/QUOTE" procedures, which are standard in seeking the best market offerings. ### Pricing and Labor Standards The contract is defined by a "FIRM FIXED PRICE" agreement, ensuring predictable costs for the government. The approach negates any uncertainty around fluctuating prices, which is crucial during periods of economic volatility. Labor standards and construction wage rates are not applicable here, suggesting that the contract primarily focuses on product delivery rather than labor-intensive service provisions. ### Alignments and Agency Collaborations Awarded by the Federal Prison System within the **Department of Justice**, the contract aligns with the system's imperative to manage healthcare provisions within federal correctional facilities. The award's funding, facilitated by the same department, ensures alignment in organizational priorities and efficient administration. ### Conclusion The McKesson Corporation contract is a representation of strategic government spending in healthcare procurement. It highlights a carefully orchestrated effort to engage a leading pharmaceutical supplier to meet essential healthcare needs within federal institutions. The detailed breakdown reveals a structured and strategic distribution of funds aligned with specific delivery points, ensuring that the procurement process is transparent and meets the stipulated objectives of federal healthcare mandates. By engaging McKesson, the Department of Justice ensures that high-quality medical products are accessible to federal facilities, underpinning effective health service delivery within set federal budgets and timelines.